Celltrion
068270.KS
#807
Rank
NZ$49.62 B
Marketcap
NZ$220.63
Share price
2.07%
Change (1 day)
14.87%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

Financial Statements

Thumbnail Celltrion
 Financial Statement 2023-2024

Financial Statement 2023-2024

Language: English

View Financial Statement
Thumbnail Celltrion
 Financial Statement 2022-2023

Financial Statement 2022-2023

Language: English

View Financial Statement
Thumbnail Celltrion
 Financial Statement 2021-2022

Financial Statement 2021-2022

Language: English

View Financial Statement
Thumbnail Celltrion
 Financial Statement 2020-2021

Financial Statement 2020-2021

Language: English

View Financial Statement
Thumbnail Celltrion
 Financial Statement 2019-2020

Financial Statement 2019-2020

Language: English

View Financial Statement
Thumbnail Celltrion
 Financial Statement 2018-2019

Financial Statement 2018-2019

Language: English

View Financial Statement
Thumbnail Celltrion
 Financial Statement 2017-2018

Financial Statement 2017-2018

Language: English

View Financial Statement
Thumbnail Celltrion
 Financial Statement 2016-2017

Financial Statement 2016-2017

Language: English

View Financial Statement
Thumbnail Celltrion
 Financial Statement 2015-2016

Financial Statement 2015-2016

Language: English

View Financial Statement
Thumbnail Celltrion
 Financial Statement 2014-2015

Financial Statement 2014-2015

Language: English

View Financial Statement
Thumbnail Celltrion
 Financial Statement 2013-2014

Financial Statement 2013-2014

Language: English

View Financial Statement